Fushine(SZ:300497)2026-03-02 13:36Group 1: Production Capacity and Plans - The current production capacity for VC products is 8,000 tons/year, with plans to increase it to 10,000 tons/year through technical upgrades, expected to be completed by Q2 2026 [3] - The company is currently maintaining stable production operations to meet customer demand [2] Group 2: Market Outlook and Pricing - The price of VC products is expected to remain stable, influenced by raw material costs, market supply-demand dynamics, and industry inventory levels [4] - The company holds a cautiously optimistic view on market demand for Q2, emphasizing cost control through lean management to enhance product competitiveness [4] Group 3: Business Goals for 2026 - The company aims to consolidate its market position in pharmaceutical manufacturing, focusing on optimizing and expanding products like tazobactam and carbapenem series [5] - In the synthetic biology sector, the company plans to accelerate the scale-up of microbial protein production, targeting an annual output of 200,000 tons, with a goal to produce 20,000 tons of microbial protein and 50,000 tons of amino acid water-soluble fertilizer [5]